Condition: Gastroesophageal Junction Adenocarcinoma
Interventions: Drug: Oxaliplatin; Capecitabine; Other: Oxaliplatin; Capecitabine; concurrent radiotherapy
Sponsor: Hebei Medical University
Recruiting - verified August 2016
from #ORL via xlomafota13 on Inoreader http://ift.tt/2c5naAg
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου